Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, Fc | 47 | 2023 | 540 | 9.850 |
Why?
|
Intestinal Mucosa | 93 | 2023 | 3038 | 7.590 |
Why?
|
Histocompatibility Antigens Class I | 49 | 2023 | 1366 | 6.980 |
Why?
|
Natural Killer T-Cells | 26 | 2021 | 315 | 6.350 |
Why?
|
Immunoglobulin G | 49 | 2023 | 4554 | 5.290 |
Why?
|
Antigens, CD1 | 38 | 2013 | 437 | 4.410 |
Why?
|
Cell Adhesion Molecules | 24 | 2022 | 1599 | 4.000 |
Why?
|
Inflammatory Bowel Diseases | 52 | 2023 | 2410 | 3.990 |
Why?
|
Paneth Cells | 21 | 2023 | 100 | 3.680 |
Why?
|
Immunity, Mucosal | 25 | 2020 | 491 | 3.670 |
Why?
|
Antigens, CD1d | 39 | 2021 | 220 | 3.580 |
Why?
|
Antigens, CD | 37 | 2022 | 4024 | 3.530 |
Why?
|
Unfolded Protein Response | 15 | 2019 | 230 | 3.110 |
Why?
|
Endoplasmic Reticulum | 15 | 2017 | 1144 | 2.740 |
Why?
|
Crohn Disease | 29 | 2023 | 2301 | 2.500 |
Why?
|
Antigen Presentation | 24 | 2022 | 1284 | 2.460 |
Why?
|
Colitis | 31 | 2022 | 1149 | 2.410 |
Why?
|
Intestines | 33 | 2022 | 1923 | 2.340 |
Why?
|
Carcinoembryonic Antigen | 13 | 2020 | 347 | 2.280 |
Why?
|
Epithelial Cells | 40 | 2023 | 3678 | 2.230 |
Why?
|
Antigen-Antibody Complex | 9 | 2020 | 517 | 2.210 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily K | 4 | 2017 | 91 | 1.980 |
Why?
|
Carrier Proteins | 18 | 2018 | 5019 | 1.870 |
Why?
|
Mucous Membrane | 8 | 2023 | 670 | 1.780 |
Why?
|
T-Lymphocytes | 51 | 2023 | 10163 | 1.680 |
Why?
|
Immune System | 6 | 2017 | 804 | 1.630 |
Why?
|
Colitis, Ulcerative | 19 | 2023 | 1901 | 1.630 |
Why?
|
Animals | 238 | 2024 | 168561 | 1.510 |
Why?
|
Immune Tolerance | 11 | 2022 | 2257 | 1.440 |
Why?
|
Lymphocyte Activation | 40 | 2022 | 5519 | 1.440 |
Why?
|
Mice | 169 | 2024 | 81045 | 1.440 |
Why?
|
Inflammation | 35 | 2024 | 10578 | 1.340 |
Why?
|
Antigens | 11 | 2023 | 1462 | 1.330 |
Why?
|
beta 2-Microglobulin | 12 | 2013 | 315 | 1.320 |
Why?
|
Interleukins | 10 | 2023 | 791 | 1.300 |
Why?
|
Receptors, IgG | 11 | 2020 | 582 | 1.270 |
Why?
|
Autoimmunity | 6 | 2022 | 1348 | 1.230 |
Why?
|
Metagenome | 9 | 2013 | 417 | 1.170 |
Why?
|
Killer Cells, Natural | 21 | 2020 | 2133 | 1.150 |
Why?
|
Albumins | 5 | 2017 | 568 | 1.140 |
Why?
|
Dendritic Cells | 21 | 2022 | 2723 | 1.100 |
Why?
|
Autophagy | 15 | 2022 | 1301 | 1.080 |
Why?
|
Antigen-Presenting Cells | 11 | 2019 | 969 | 1.060 |
Why?
|
Immunity | 4 | 2019 | 1011 | 1.050 |
Why?
|
Mice, Inbred C57BL | 67 | 2024 | 21821 | 1.040 |
Why?
|
Immunoglobulin Fc Fragments | 6 | 2018 | 279 | 1.020 |
Why?
|
Mice, Knockout | 50 | 2023 | 14554 | 1.010 |
Why?
|
Ileitis | 5 | 2023 | 44 | 0.990 |
Why?
|
Protein Transport | 19 | 2019 | 1988 | 0.980 |
Why?
|
Receptors, Cytokine | 11 | 2011 | 261 | 0.900 |
Why?
|
CD4-Positive T-Lymphocytes | 15 | 2023 | 4379 | 0.890 |
Why?
|
Thymus Gland | 7 | 2022 | 1264 | 0.880 |
Why?
|
Recombinant Fusion Proteins | 8 | 2018 | 3770 | 0.860 |
Why?
|
Listeriosis | 2 | 2021 | 149 | 0.830 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 15 | 2007 | 804 | 0.830 |
Why?
|
Antigens, Differentiation | 11 | 2007 | 926 | 0.810 |
Why?
|
Cross-Priming | 2 | 2012 | 82 | 0.810 |
Why?
|
Immunoglobulin A | 4 | 2021 | 992 | 0.770 |
Why?
|
Gastroenterology | 5 | 2016 | 534 | 0.760 |
Why?
|
Galactosylceramides | 5 | 2021 | 92 | 0.760 |
Why?
|
Stress, Physiological | 7 | 2017 | 1402 | 0.750 |
Why?
|
Mice, Inbred BALB C | 25 | 2018 | 6382 | 0.740 |
Why?
|
Humans | 272 | 2023 | 742088 | 0.730 |
Why?
|
T-Lymphocytes, Cytotoxic | 6 | 2015 | 1820 | 0.730 |
Why?
|
Niemann-Pick Diseases | 1 | 2019 | 28 | 0.730 |
Why?
|
T-Lymphocyte Subsets | 14 | 2016 | 1837 | 0.720 |
Why?
|
Signal Transduction | 32 | 2022 | 23387 | 0.710 |
Why?
|
Lipids | 9 | 2024 | 3302 | 0.700 |
Why?
|
Th17 Cells | 3 | 2023 | 765 | 0.700 |
Why?
|
Sphingomyelins | 1 | 2019 | 105 | 0.690 |
Why?
|
Sphingomyelin Phosphodiesterase | 1 | 2019 | 91 | 0.690 |
Why?
|
Receptors, Antigen, T-Cell | 16 | 2022 | 2524 | 0.680 |
Why?
|
Immunologic Techniques | 1 | 2019 | 218 | 0.650 |
Why?
|
Factor VIII | 2 | 2018 | 348 | 0.650 |
Why?
|
Thromboplastin | 1 | 2020 | 291 | 0.640 |
Why?
|
Interleukin-10 | 8 | 2018 | 1200 | 0.630 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 6 | 2017 | 122 | 0.630 |
Why?
|
Hepatocytes | 7 | 2022 | 1209 | 0.630 |
Why?
|
Cell Polarity | 10 | 2011 | 644 | 0.610 |
Why?
|
Autoimmune Diseases | 6 | 2019 | 2130 | 0.610 |
Why?
|
Crystallography, X-Ray | 2 | 2021 | 2014 | 0.610 |
Why?
|
Hemophilia A | 2 | 2018 | 351 | 0.600 |
Why?
|
Gastrointestinal Tract | 7 | 2021 | 814 | 0.600 |
Why?
|
Health | 2 | 2012 | 390 | 0.590 |
Why?
|
Epithelium | 16 | 2015 | 1680 | 0.590 |
Why?
|
Adaptive Immunity | 5 | 2020 | 712 | 0.590 |
Why?
|
Homeostasis | 11 | 2021 | 3335 | 0.590 |
Why?
|
Immunity, Innate | 10 | 2020 | 2956 | 0.580 |
Why?
|
Oxazoles | 1 | 2018 | 189 | 0.580 |
Why?
|
Protein Binding | 20 | 2019 | 9387 | 0.580 |
Why?
|
Cell Line | 44 | 2020 | 15994 | 0.570 |
Why?
|
Glycoproteins | 7 | 2008 | 2260 | 0.570 |
Why?
|
Symbiosis | 6 | 2021 | 283 | 0.560 |
Why?
|
Cytokines | 25 | 2021 | 7317 | 0.560 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2018 | 209 | 0.550 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 5 | 2004 | 867 | 0.540 |
Why?
|
Vacuolar Proton-Translocating ATPases | 6 | 2011 | 195 | 0.540 |
Why?
|
Antibodies, Monoclonal | 19 | 2019 | 9274 | 0.540 |
Why?
|
Disease Models, Animal | 36 | 2021 | 18006 | 0.540 |
Why?
|
PPAR gamma | 3 | 2008 | 493 | 0.540 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2018 | 507 | 0.540 |
Why?
|
Serotonin | 1 | 2020 | 1024 | 0.540 |
Why?
|
Colon | 14 | 2021 | 1773 | 0.530 |
Why?
|
Transcription Factors | 14 | 2023 | 12164 | 0.520 |
Why?
|
Protein Isoforms | 9 | 2017 | 1727 | 0.520 |
Why?
|
Immunity, Humoral | 1 | 2019 | 596 | 0.520 |
Why?
|
Placenta | 4 | 2019 | 1694 | 0.520 |
Why?
|
Cytotoxicity, Immunologic | 13 | 2011 | 1368 | 0.510 |
Why?
|
Hypersensitivity | 6 | 2017 | 1093 | 0.510 |
Why?
|
Intestine, Small | 10 | 2023 | 1243 | 0.510 |
Why?
|
Interleukin-15 | 1 | 2015 | 184 | 0.500 |
Why?
|
Dextran Sulfate | 10 | 2022 | 236 | 0.500 |
Why?
|
Celiac Disease | 2 | 2015 | 785 | 0.500 |
Why?
|
Intestinal Diseases | 3 | 2013 | 531 | 0.500 |
Why?
|
Ligands | 10 | 2014 | 3293 | 0.490 |
Why?
|
Interferon-gamma | 14 | 2012 | 3199 | 0.490 |
Why?
|
Protein Processing, Post-Translational | 6 | 2018 | 1989 | 0.480 |
Why?
|
Transcytosis | 5 | 2017 | 44 | 0.480 |
Why?
|
Mice, Transgenic | 20 | 2023 | 9735 | 0.470 |
Why?
|
Leukotrienes | 1 | 2015 | 255 | 0.470 |
Why?
|
Abetalipoproteinemia | 3 | 2012 | 17 | 0.470 |
Why?
|
Bacteria | 6 | 2012 | 2102 | 0.460 |
Why?
|
Models, Immunological | 3 | 2007 | 527 | 0.460 |
Why?
|
Up-Regulation | 17 | 2017 | 4211 | 0.450 |
Why?
|
Immunity, Active | 2 | 2013 | 60 | 0.440 |
Why?
|
Heparin | 1 | 2020 | 1636 | 0.440 |
Why?
|
Ileum | 6 | 2023 | 565 | 0.430 |
Why?
|
Thiazolidinediones | 4 | 2008 | 476 | 0.430 |
Why?
|
Receptors, Interleukin-17 | 2 | 2023 | 69 | 0.420 |
Why?
|
Macrophages | 10 | 2021 | 5655 | 0.420 |
Why?
|
Membrane Proteins | 12 | 2021 | 7873 | 0.420 |
Why?
|
Cysteine | 2 | 2015 | 873 | 0.420 |
Why?
|
Reperfusion Injury | 3 | 2010 | 1025 | 0.420 |
Why?
|
Thrombocytopenia | 1 | 2020 | 1171 | 0.420 |
Why?
|
Protein Conformation | 6 | 2021 | 4013 | 0.420 |
Why?
|
Th2 Cells | 6 | 2008 | 1049 | 0.410 |
Why?
|
Cell Differentiation | 15 | 2023 | 11470 | 0.410 |
Why?
|
DNA-Binding Proteins | 11 | 2013 | 9639 | 0.400 |
Why?
|
Caspase 3 | 1 | 2014 | 759 | 0.400 |
Why?
|
Immune System Diseases | 1 | 2014 | 262 | 0.400 |
Why?
|
Enteritis | 3 | 2022 | 160 | 0.400 |
Why?
|
Oxazolone | 7 | 2018 | 60 | 0.390 |
Why?
|
Cell Transformation, Neoplastic | 5 | 2021 | 2940 | 0.390 |
Why?
|
Mucus | 3 | 2022 | 321 | 0.390 |
Why?
|
Common Variable Immunodeficiency | 1 | 2012 | 93 | 0.390 |
Why?
|
Receptors, Virus | 1 | 2014 | 648 | 0.390 |
Why?
|
Major Histocompatibility Complex | 8 | 2008 | 935 | 0.380 |
Why?
|
Placental Circulation | 1 | 2010 | 40 | 0.380 |
Why?
|
Nod2 Signaling Adaptor Protein | 4 | 2011 | 87 | 0.370 |
Why?
|
Liver | 14 | 2024 | 7470 | 0.370 |
Why?
|
Cell Membrane | 14 | 2009 | 3744 | 0.370 |
Why?
|
Cell Proliferation | 14 | 2021 | 10472 | 0.370 |
Why?
|
Macaca fascicularis | 2 | 2019 | 908 | 0.360 |
Why?
|
Enterocytes | 1 | 2011 | 225 | 0.360 |
Why?
|
Gene Expression Regulation | 16 | 2016 | 12071 | 0.360 |
Why?
|
Protein Engineering | 3 | 2012 | 541 | 0.360 |
Why?
|
Interleukin-12 | 5 | 2012 | 579 | 0.360 |
Why?
|
Caco-2 Cells | 9 | 2023 | 387 | 0.350 |
Why?
|
Intestinal Neoplasms | 3 | 2021 | 319 | 0.350 |
Why?
|
Stem Cells | 7 | 2022 | 3563 | 0.350 |
Why?
|
NF-kappa B | 10 | 2023 | 2500 | 0.340 |
Why?
|
Receptors, Interleukin | 4 | 2020 | 245 | 0.340 |
Why?
|
Flow Cytometry | 13 | 2023 | 5975 | 0.340 |
Why?
|
Lymphoid Tissue | 4 | 2011 | 455 | 0.340 |
Why?
|
B-Lymphocytes | 12 | 2021 | 4664 | 0.330 |
Why?
|
Tumor Escape | 1 | 2011 | 349 | 0.330 |
Why?
|
Hepatitis B virus | 1 | 2012 | 513 | 0.330 |
Why?
|
Gonadal Steroid Hormones | 1 | 2013 | 711 | 0.330 |
Why?
|
Flagellin | 1 | 2009 | 125 | 0.330 |
Why?
|
ZAP-70 Protein-Tyrosine Kinase | 1 | 2008 | 67 | 0.320 |
Why?
|
Genetic Predisposition to Disease | 10 | 2022 | 17400 | 0.310 |
Why?
|
Bile | 2 | 2020 | 296 | 0.310 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2021 | 8425 | 0.310 |
Why?
|
Dogs | 7 | 2017 | 3910 | 0.310 |
Why?
|
Hepatitis B, Chronic | 1 | 2012 | 393 | 0.310 |
Why?
|
TCF Transcription Factors | 1 | 2008 | 140 | 0.310 |
Why?
|
Amino Acid Sequence | 22 | 2018 | 13814 | 0.310 |
Why?
|
Dimerization | 4 | 2014 | 893 | 0.310 |
Why?
|
Protein Multimerization | 3 | 2021 | 971 | 0.310 |
Why?
|
Interferon Type I | 2 | 2011 | 542 | 0.310 |
Why?
|
Serum Albumin | 2 | 2018 | 674 | 0.310 |
Why?
|
Transfection | 14 | 2008 | 5892 | 0.300 |
Why?
|
Digestive System | 2 | 2007 | 251 | 0.300 |
Why?
|
Mucositis | 1 | 2008 | 101 | 0.300 |
Why?
|
Protein Subunits | 8 | 2006 | 960 | 0.300 |
Why?
|
Membrane Glycoproteins | 9 | 2011 | 3769 | 0.300 |
Why?
|
HT29 Cells | 6 | 2020 | 200 | 0.300 |
Why?
|
Bacteroides fragilis | 2 | 2021 | 212 | 0.300 |
Why?
|
CD8-Positive T-Lymphocytes | 13 | 2023 | 4438 | 0.300 |
Why?
|
Receptors, IgE | 3 | 2014 | 389 | 0.300 |
Why?
|
Bile Ducts | 3 | 2018 | 284 | 0.300 |
Why?
|
Maternal-Fetal Exchange | 4 | 2018 | 455 | 0.290 |
Why?
|
Genes, MHC Class I | 3 | 2001 | 258 | 0.290 |
Why?
|
Germ-Free Life | 2 | 2021 | 188 | 0.290 |
Why?
|
Immunity, Cellular | 8 | 2011 | 1606 | 0.290 |
Why?
|
Neoplasms | 8 | 2020 | 21596 | 0.290 |
Why?
|
Microsomes | 1 | 2007 | 257 | 0.290 |
Why?
|
Gastrointestinal Agents | 1 | 2012 | 494 | 0.290 |
Why?
|
Tyrosine | 3 | 2012 | 1460 | 0.290 |
Why?
|
Cholangitis | 2 | 2018 | 108 | 0.280 |
Why?
|
Lung | 6 | 2017 | 9826 | 0.280 |
Why?
|
Stomach | 5 | 2011 | 697 | 0.280 |
Why?
|
Macrophages, Peritoneal | 2 | 2010 | 251 | 0.280 |
Why?
|
Tumor Necrosis Factor-alpha | 11 | 2012 | 4414 | 0.280 |
Why?
|
Cells, Cultured | 30 | 2020 | 19223 | 0.280 |
Why?
|
Clone Cells | 5 | 2004 | 1692 | 0.280 |
Why?
|
Polysaccharides | 2 | 2012 | 1051 | 0.270 |
Why?
|
Calnexin | 1 | 2005 | 26 | 0.270 |
Why?
|
Molecular Sequence Data | 28 | 2007 | 18112 | 0.270 |
Why?
|
Colonic Neoplasms | 3 | 2020 | 2542 | 0.270 |
Why?
|
Polymerase Chain Reaction | 15 | 2015 | 6171 | 0.270 |
Why?
|
Isomerases | 1 | 2005 | 56 | 0.270 |
Why?
|
Lipid Metabolism | 2 | 2024 | 1887 | 0.260 |
Why?
|
Acetaminophen | 2 | 2022 | 544 | 0.260 |
Why?
|
NFATC Transcription Factors | 3 | 2016 | 380 | 0.260 |
Why?
|
Alternative Splicing | 2 | 2008 | 1118 | 0.260 |
Why?
|
Career Choice | 1 | 2011 | 743 | 0.250 |
Why?
|
Lysosomes | 5 | 2019 | 893 | 0.250 |
Why?
|
Immunologic Memory | 4 | 2014 | 1348 | 0.250 |
Why?
|
Immunotherapy | 5 | 2020 | 4414 | 0.250 |
Why?
|
T-Lymphocytes, Helper-Inducer | 3 | 2008 | 986 | 0.250 |
Why?
|
Myeloid Cells | 2 | 2007 | 804 | 0.250 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2014 | 15494 | 0.250 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 2 | 2018 | 109 | 0.250 |
Why?
|
Gastrointestinal Diseases | 1 | 2013 | 1167 | 0.250 |
Why?
|
Male | 65 | 2023 | 349538 | 0.240 |
Why?
|
Colorectal Neoplasms | 7 | 2016 | 6754 | 0.240 |
Why?
|
Environment | 1 | 2010 | 1115 | 0.240 |
Why?
|
Minor Histocompatibility Antigens | 9 | 2011 | 298 | 0.240 |
Why?
|
Female | 63 | 2023 | 379592 | 0.240 |
Why?
|
Genes, MHC Class II | 2 | 2023 | 458 | 0.240 |
Why?
|
Chlamydia | 1 | 2023 | 33 | 0.230 |
Why?
|
Interleukin-4 | 7 | 2018 | 1146 | 0.230 |
Why?
|
Lymphocyte Subsets | 3 | 1999 | 315 | 0.230 |
Why?
|
Monocytes | 3 | 2020 | 2593 | 0.230 |
Why?
|
Arthritis, Experimental | 1 | 2006 | 291 | 0.230 |
Why?
|
Amino Acid Motifs | 4 | 2012 | 936 | 0.230 |
Why?
|
Inhibitor of Apoptosis Proteins | 2 | 2017 | 215 | 0.230 |
Why?
|
Liver Diseases | 2 | 2023 | 1252 | 0.230 |
Why?
|
Acquired Immunodeficiency Syndrome | 8 | 2010 | 2231 | 0.230 |
Why?
|
Asthma | 5 | 2016 | 5955 | 0.230 |
Why?
|
Caenorhabditis elegans Proteins | 1 | 2010 | 849 | 0.230 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 7 | 1991 | 906 | 0.230 |
Why?
|
Mast Cells | 4 | 2014 | 1544 | 0.230 |
Why?
|
Base Sequence | 18 | 2005 | 12797 | 0.230 |
Why?
|
Cholera Toxin | 2 | 2005 | 553 | 0.220 |
Why?
|
Exocytosis | 1 | 2005 | 353 | 0.220 |
Why?
|
Apoptosis | 11 | 2021 | 9715 | 0.220 |
Why?
|
Faculty, Medical | 1 | 2011 | 1182 | 0.220 |
Why?
|
Activating Transcription Factor 6 | 2 | 2020 | 28 | 0.220 |
Why?
|
Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 2 | 2007 | 97 | 0.220 |
Why?
|
Mice, Mutant Strains | 4 | 2021 | 1866 | 0.220 |
Why?
|
Receptor-CD3 Complex, Antigen, T-Cell | 3 | 2000 | 67 | 0.220 |
Why?
|
beta Catenin | 1 | 2008 | 1058 | 0.220 |
Why?
|
Tumor Necrosis Factors | 2 | 2017 | 109 | 0.220 |
Why?
|
Gastric Mucosa | 3 | 2004 | 598 | 0.220 |
Why?
|
Jurkat Cells | 5 | 2017 | 742 | 0.210 |
Why?
|
Sex Characteristics | 1 | 2013 | 2585 | 0.210 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2021 | 3617 | 0.210 |
Why?
|
Down-Regulation | 6 | 2012 | 3001 | 0.210 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2014 | 3336 | 0.200 |
Why?
|
Staining and Labeling | 2 | 2019 | 1099 | 0.200 |
Why?
|
Carbohydrates | 2 | 2022 | 391 | 0.200 |
Why?
|
Sequence Homology, Amino Acid | 4 | 2018 | 2837 | 0.200 |
Why?
|
Disease Susceptibility | 4 | 2020 | 1780 | 0.200 |
Why?
|
Awards and Prizes | 1 | 2006 | 375 | 0.200 |
Why?
|
Goblet Cells | 4 | 2021 | 287 | 0.200 |
Why?
|
Endoribonucleases | 3 | 2022 | 228 | 0.200 |
Why?
|
Cell Communication | 2 | 2022 | 1619 | 0.200 |
Why?
|
Anti-Bacterial Agents | 2 | 2023 | 7153 | 0.200 |
Why?
|
Blotting, Western | 10 | 2016 | 5180 | 0.200 |
Why?
|
Heat-Shock Proteins | 1 | 2005 | 822 | 0.190 |
Why?
|
Fluorometry | 1 | 2021 | 106 | 0.190 |
Why?
|
Organoids | 3 | 2022 | 692 | 0.190 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2003 | 404 | 0.190 |
Why?
|
Cytoplasm | 4 | 2012 | 1539 | 0.190 |
Why?
|
Infant, Newborn | 10 | 2023 | 25575 | 0.190 |
Why?
|
Caenorhabditis elegans | 1 | 2010 | 1416 | 0.190 |
Why?
|
Autocrine Communication | 2 | 2013 | 171 | 0.190 |
Why?
|
Enterochromaffin Cells | 1 | 2020 | 15 | 0.190 |
Why?
|
Cell Line, Tumor | 13 | 2020 | 16665 | 0.190 |
Why?
|
Antibody Formation | 4 | 2004 | 1402 | 0.190 |
Why?
|
Binding Sites | 5 | 2022 | 6115 | 0.190 |
Why?
|
Academic Medical Centers | 1 | 2011 | 2749 | 0.190 |
Why?
|
Tryptophan | 2 | 2018 | 478 | 0.190 |
Why?
|
RNA Interference | 3 | 2018 | 2890 | 0.190 |
Why?
|
Receptors, Immunologic | 5 | 2016 | 1423 | 0.190 |
Why?
|
Specific Pathogen-Free Organisms | 2 | 2012 | 226 | 0.190 |
Why?
|
Procollagen-Proline Dioxygenase | 1 | 2000 | 86 | 0.190 |
Why?
|
Erythropoietin | 2 | 2004 | 724 | 0.190 |
Why?
|
Pemphigus | 1 | 2021 | 103 | 0.180 |
Why?
|
Adjuvants, Immunologic | 2 | 2005 | 1000 | 0.180 |
Why?
|
Diphtheria Toxin | 1 | 2021 | 255 | 0.180 |
Why?
|
Antigens, Neoplasm | 3 | 2010 | 1983 | 0.180 |
Why?
|
HSP110 Heat-Shock Proteins | 2 | 2014 | 10 | 0.180 |
Why?
|
Autoantigens | 2 | 2022 | 891 | 0.180 |
Why?
|
Lectins | 1 | 2022 | 514 | 0.180 |
Why?
|
eIF-2 Kinase | 3 | 2019 | 150 | 0.180 |
Why?
|
Platelet Factor 4 | 1 | 2020 | 129 | 0.180 |
Why?
|
Interleukin-13 | 3 | 2011 | 389 | 0.180 |
Why?
|
Peptide Fragments | 3 | 2009 | 5095 | 0.180 |
Why?
|
Diet | 1 | 2018 | 7923 | 0.180 |
Why?
|
Th1 Cells | 6 | 2011 | 1056 | 0.180 |
Why?
|
HLA Antigens | 3 | 2007 | 1382 | 0.170 |
Why?
|
Pseudomonas aeruginosa | 2 | 2009 | 1210 | 0.170 |
Why?
|
HIV | 6 | 2014 | 1600 | 0.170 |
Why?
|
N-Acetylglucosaminyltransferases | 2 | 2018 | 171 | 0.170 |
Why?
|
Tumor Cells, Cultured | 9 | 2015 | 6313 | 0.170 |
Why?
|
Enzyme Replacement Therapy | 1 | 2019 | 78 | 0.170 |
Why?
|
Leukocytes | 5 | 2010 | 2039 | 0.170 |
Why?
|
Lymphocyte Count | 2 | 2019 | 792 | 0.170 |
Why?
|
Endocytosis | 4 | 2017 | 983 | 0.170 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2021 | 249 | 0.170 |
Why?
|
Glycosphingolipids | 3 | 2019 | 79 | 0.170 |
Why?
|
Salmonella typhi | 1 | 2020 | 200 | 0.170 |
Why?
|
Citrobacter rodentium | 2 | 2010 | 65 | 0.170 |
Why?
|
Typhoid Fever | 1 | 2020 | 196 | 0.170 |
Why?
|
Immunoglobulin E | 2 | 2015 | 1460 | 0.170 |
Why?
|
Antigens, Surface | 4 | 1999 | 1663 | 0.170 |
Why?
|
beta-N-Acetylhexosaminidases | 1 | 2018 | 53 | 0.170 |
Why?
|
Listeria monocytogenes | 2 | 2012 | 250 | 0.160 |
Why?
|
Food Hypersensitivity | 2 | 2017 | 622 | 0.160 |
Why?
|
Strongylida Infections | 1 | 2018 | 46 | 0.160 |
Why?
|
Immunosuppressive Agents | 4 | 2006 | 4147 | 0.160 |
Why?
|
DNA Primers | 7 | 2005 | 2892 | 0.160 |
Why?
|
Purines | 1 | 2022 | 593 | 0.160 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2022 | 1158 | 0.160 |
Why?
|
Nuclear Proteins | 2 | 2022 | 5851 | 0.160 |
Why?
|
Biotechnology | 1 | 2000 | 278 | 0.160 |
Why?
|
Factor IX | 1 | 2018 | 77 | 0.160 |
Why?
|
Receptors, Calcitriol | 1 | 2020 | 350 | 0.160 |
Why?
|
Phagocytosis | 3 | 2021 | 1538 | 0.160 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 9 | 2015 | 3862 | 0.160 |
Why?
|
Tissue Culture Techniques | 1 | 2019 | 291 | 0.150 |
Why?
|
Ovalbumin | 5 | 2017 | 719 | 0.150 |
Why?
|
Oncostatin M | 1 | 2017 | 28 | 0.150 |
Why?
|
Pseudomonas Infections | 1 | 2002 | 608 | 0.150 |
Why?
|
Protein Structure, Tertiary | 6 | 2013 | 3847 | 0.150 |
Why?
|
Hemophilia B | 1 | 2018 | 81 | 0.150 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2020 | 547 | 0.150 |
Why?
|
Fluorescent Antibody Technique | 6 | 2010 | 2505 | 0.150 |
Why?
|
T-Lymphocytes, Regulatory | 6 | 2018 | 2986 | 0.150 |
Why?
|
Coculture Techniques | 5 | 2019 | 1341 | 0.150 |
Why?
|
Phosphorylation | 6 | 2013 | 8436 | 0.150 |
Why?
|
Metabolic Diseases | 1 | 2024 | 657 | 0.150 |
Why?
|
Models, Molecular | 4 | 2021 | 5454 | 0.150 |
Why?
|
Enterobacteriaceae Infections | 2 | 2010 | 186 | 0.150 |
Why?
|
Adenoviridae | 4 | 2012 | 1096 | 0.150 |
Why?
|
Hydrogen-Ion Concentration | 3 | 2011 | 2552 | 0.150 |
Why?
|
Isoantibodies | 2 | 2018 | 680 | 0.150 |
Why?
|
Chemokines, CXC | 2 | 2014 | 422 | 0.140 |
Why?
|
Acetylglucosamine | 1 | 2018 | 191 | 0.140 |
Why?
|
Common Bile Duct | 1 | 1997 | 109 | 0.140 |
Why?
|
Autoantibodies | 3 | 2021 | 2036 | 0.140 |
Why?
|
Nucleotidyltransferases | 1 | 2018 | 220 | 0.140 |
Why?
|
Infertility | 1 | 2023 | 655 | 0.140 |
Why?
|
Bile Duct Diseases | 1 | 2017 | 100 | 0.140 |
Why?
|
RNA, Small Interfering | 2 | 2018 | 3504 | 0.140 |
Why?
|
Structure-Activity Relationship | 3 | 2021 | 3133 | 0.140 |
Why?
|
Receptors, Guanylate Cyclase-Coupled | 1 | 2016 | 13 | 0.140 |
Why?
|
Dermatitis, Contact | 2 | 2008 | 129 | 0.140 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 2 | 1996 | 341 | 0.140 |
Why?
|
Immunoenzyme Techniques | 5 | 2010 | 1799 | 0.140 |
Why?
|
Promoter Regions, Genetic | 2 | 2007 | 5867 | 0.140 |
Why?
|
Immunomodulation | 2 | 2018 | 540 | 0.140 |
Why?
|
Antigens, Bacterial | 2 | 2014 | 1170 | 0.140 |
Why?
|
Protein Folding | 2 | 2010 | 843 | 0.140 |
Why?
|
Interleukin-17 | 3 | 2023 | 900 | 0.140 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2022 | 1114 | 0.130 |
Why?
|
STAT Transcription Factors | 2 | 2018 | 182 | 0.130 |
Why?
|
STAT3 Transcription Factor | 4 | 2014 | 874 | 0.130 |
Why?
|
Biomedical Research | 1 | 2011 | 3306 | 0.130 |
Why?
|
CD4 Lymphocyte Count | 4 | 2014 | 2557 | 0.130 |
Why?
|
DNA, Complementary | 5 | 2004 | 2049 | 0.130 |
Why?
|
Gastrointestinal Hormones | 1 | 2016 | 97 | 0.130 |
Why?
|
Plasma Cells | 1 | 2019 | 592 | 0.130 |
Why?
|
Ion Channels | 1 | 2020 | 1056 | 0.130 |
Why?
|
Protein Kinase C | 3 | 2016 | 1227 | 0.130 |
Why?
|
Isoenzymes | 3 | 2016 | 1725 | 0.130 |
Why?
|
Interleukin-2 | 5 | 2013 | 1887 | 0.130 |
Why?
|
Calcineurin | 1 | 2016 | 226 | 0.130 |
Why?
|
Disease | 2 | 2013 | 681 | 0.130 |
Why?
|
Receptors, Cell Surface | 3 | 2011 | 2867 | 0.130 |
Why?
|
RNA, Messenger | 15 | 2011 | 13029 | 0.130 |
Why?
|
RNA, Ribosomal, 16S | 3 | 2020 | 947 | 0.130 |
Why?
|
Embryo, Mammalian | 1 | 2021 | 1692 | 0.130 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2021 | 2915 | 0.130 |
Why?
|
Orthomyxoviridae | 1 | 2016 | 156 | 0.130 |
Why?
|
Interleukin-23 | 2 | 2016 | 193 | 0.120 |
Why?
|
Mastocytosis | 1 | 2017 | 160 | 0.120 |
Why?
|
Natriuretic Peptides | 1 | 2016 | 150 | 0.120 |
Why?
|
HeLa Cells | 3 | 2008 | 3127 | 0.120 |
Why?
|
Biological Assay | 1 | 2018 | 652 | 0.120 |
Why?
|
Bacteriophages | 1 | 2017 | 354 | 0.120 |
Why?
|
Egg Hypersensitivity | 1 | 2014 | 44 | 0.120 |
Why?
|
U937 Cells | 3 | 2005 | 268 | 0.120 |
Why?
|
Receptors, Peptide | 1 | 2016 | 272 | 0.120 |
Why?
|
Chlamydia muridarum | 1 | 2014 | 9 | 0.120 |
Why?
|
Repressor Proteins | 2 | 2020 | 3020 | 0.120 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2018 | 546 | 0.120 |
Why?
|
HEK293 Cells | 4 | 2020 | 4200 | 0.120 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2022 | 1221 | 0.120 |
Why?
|
Perfusion | 1 | 2019 | 1359 | 0.120 |
Why?
|
src-Family Kinases | 1 | 2017 | 551 | 0.120 |
Why?
|
Spleen | 5 | 2017 | 2359 | 0.120 |
Why?
|
Biological Transport | 5 | 2005 | 2119 | 0.120 |
Why?
|
Arginine | 2 | 2004 | 944 | 0.120 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 3 | 2014 | 304 | 0.120 |
Why?
|
Mutation | 10 | 2021 | 29717 | 0.120 |
Why?
|
Pregnancy | 10 | 2019 | 29087 | 0.120 |
Why?
|
Receptors, Polymeric Immunoglobulin | 1 | 2013 | 4 | 0.120 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 2015 | 349 | 0.120 |
Why?
|
Polymorphism, Genetic | 3 | 2010 | 4328 | 0.120 |
Why?
|
Receptors, Scavenger | 1 | 2014 | 121 | 0.120 |
Why?
|
Intercellular Adhesion Molecule-1 | 4 | 2005 | 1155 | 0.110 |
Why?
|
Streptococcus agalactiae | 1 | 1995 | 375 | 0.110 |
Why?
|
Eicosapentaenoic Acid | 2 | 2010 | 582 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-vav | 1 | 2013 | 95 | 0.110 |
Why?
|
Cytomegalovirus | 2 | 2016 | 730 | 0.110 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 4 | 1999 | 1801 | 0.110 |
Why?
|
Allergens | 2 | 2017 | 1314 | 0.110 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2017 | 325 | 0.110 |
Why?
|
Penetrance | 1 | 2014 | 380 | 0.110 |
Why?
|
Adoptive Transfer | 2 | 2006 | 844 | 0.110 |
Why?
|
Diet Therapy | 1 | 2014 | 154 | 0.110 |
Why?
|
Graft vs Host Disease | 2 | 2018 | 2951 | 0.110 |
Why?
|
Cytosol | 2 | 2017 | 901 | 0.110 |
Why?
|
Antigens, Viral | 2 | 1987 | 1034 | 0.110 |
Why?
|
Cell Cycle Proteins | 2 | 2021 | 3444 | 0.110 |
Why?
|
Phospholipases A2, Secretory | 1 | 2012 | 31 | 0.110 |
Why?
|
Chemokine CXCL6 | 1 | 2012 | 13 | 0.110 |
Why?
|
Antibodies | 3 | 2019 | 2459 | 0.110 |
Why?
|
Animals, Newborn | 4 | 2014 | 2723 | 0.110 |
Why?
|
Protein Phosphatase 1 | 2 | 2004 | 137 | 0.110 |
Why?
|
Precipitin Tests | 5 | 1999 | 829 | 0.110 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2022 | 1341 | 0.110 |
Why?
|
rab GTP-Binding Proteins | 2 | 2011 | 246 | 0.110 |
Why?
|
Toll-Like Receptor 4 | 2 | 2014 | 561 | 0.110 |
Why?
|
Helicobacter heilmannii | 1 | 2011 | 5 | 0.100 |
Why?
|
Interleukin-12 Subunit p35 | 2 | 2011 | 20 | 0.100 |
Why?
|
Tumor Suppressor Proteins | 2 | 2021 | 2842 | 0.100 |
Why?
|
Liver Transplantation | 1 | 2023 | 2117 | 0.100 |
Why?
|
Research | 1 | 2001 | 1999 | 0.100 |
Why?
|
Receptors, CXCR | 1 | 2012 | 52 | 0.100 |
Why?
|
Chromans | 2 | 2002 | 122 | 0.100 |
Why?
|
Cloning, Molecular | 6 | 2005 | 4322 | 0.100 |
Why?
|
Thapsigargin | 2 | 2023 | 104 | 0.100 |
Why?
|
Gene Deletion | 2 | 2017 | 2751 | 0.100 |
Why?
|
Cell Survival | 5 | 2022 | 5872 | 0.100 |
Why?
|
Herpesvirus 4, Human | 2 | 1987 | 1040 | 0.100 |
Why?
|
Genes, RAG-1 | 2 | 2002 | 68 | 0.100 |
Why?
|
DNA Damage | 1 | 2021 | 2423 | 0.100 |
Why?
|
Antibodies, Bacterial | 3 | 2014 | 1469 | 0.100 |
Why?
|
Rats | 11 | 2010 | 24265 | 0.100 |
Why?
|
Eosinophilic Esophagitis | 1 | 2014 | 163 | 0.100 |
Why?
|
Graft vs Tumor Effect | 1 | 2011 | 72 | 0.100 |
Why?
|
Paracrine Communication | 2 | 2016 | 276 | 0.100 |
Why?
|
Neutrophils | 3 | 2020 | 3711 | 0.100 |
Why?
|
Hepatitis B Surface Antigens | 1 | 2012 | 305 | 0.100 |
Why?
|
Immunohistochemistry | 11 | 2018 | 11363 | 0.100 |
Why?
|
Antibodies, Viral | 3 | 2014 | 3164 | 0.100 |
Why?
|
Antibody Specificity | 4 | 2001 | 1094 | 0.100 |
Why?
|
Streptococcal Infections | 1 | 1995 | 637 | 0.100 |
Why?
|
Mitochondria | 2 | 2023 | 3520 | 0.100 |
Why?
|
Age of Onset | 2 | 2014 | 3266 | 0.090 |
Why?
|
Feedback, Physiological | 2 | 2014 | 479 | 0.090 |
Why?
|
Cyclooxygenase 2 | 2 | 2011 | 611 | 0.090 |
Why?
|
Bacterial Translocation | 1 | 2010 | 73 | 0.090 |
Why?
|
Adenoma | 1 | 2021 | 2168 | 0.090 |
Why?
|
Maternal Exposure | 1 | 2017 | 961 | 0.090 |
Why?
|
Protein Tyrosine Phosphatases | 2 | 2004 | 473 | 0.090 |
Why?
|
ATP-Binding Cassette Transporters | 2 | 2004 | 559 | 0.090 |
Why?
|
Immune System Phenomena | 1 | 2010 | 16 | 0.090 |
Why?
|
Diverticulitis | 3 | 1999 | 169 | 0.090 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2021 | 3760 | 0.090 |
Why?
|
Transforming Growth Factor beta | 1 | 2018 | 2006 | 0.090 |
Why?
|
Thiazoles | 4 | 2018 | 1484 | 0.090 |
Why?
|
Interphase | 2 | 2002 | 224 | 0.090 |
Why?
|
Apolipoproteins B | 1 | 2012 | 373 | 0.090 |
Why?
|
HIV Enteropathy | 1 | 2009 | 6 | 0.090 |
Why?
|
Chlamydia Infections | 1 | 2014 | 364 | 0.090 |
Why?
|
Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 2 | 2008 | 91 | 0.090 |
Why?
|
Genome | 1 | 2019 | 1803 | 0.090 |
Why?
|
RNA | 1 | 2020 | 2747 | 0.090 |
Why?
|
Trinitrobenzenesulfonic Acid | 2 | 2010 | 68 | 0.090 |
Why?
|
Phagosomes | 1 | 2011 | 193 | 0.090 |
Why?
|
Caveolins | 2 | 2000 | 104 | 0.090 |
Why?
|
Galectin 4 | 2 | 2012 | 22 | 0.090 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 1 | 2014 | 570 | 0.090 |
Why?
|
Solubility | 4 | 2006 | 1083 | 0.090 |
Why?
|
Lysophospholipids | 1 | 2012 | 331 | 0.090 |
Why?
|
Enterocolitis, Necrotizing | 1 | 2014 | 340 | 0.090 |
Why?
|
Tryptases | 1 | 2010 | 190 | 0.090 |
Why?
|
Lipopolysaccharides | 5 | 2014 | 2211 | 0.090 |
Why?
|
Deltaretrovirus | 2 | 1986 | 170 | 0.090 |
Why?
|
Arthritis, Rheumatoid | 2 | 2020 | 3695 | 0.090 |
Why?
|
Models, Biological | 4 | 2011 | 9581 | 0.090 |
Why?
|
History, 20th Century | 2 | 2008 | 2739 | 0.090 |
Why?
|
alpha-Defensins | 1 | 2008 | 28 | 0.080 |
Why?
|
Cromolyn Sodium | 1 | 2009 | 87 | 0.080 |
Why?
|
Antigens, Plant | 1 | 2009 | 86 | 0.080 |
Why?
|
Interferon-beta | 1 | 2011 | 323 | 0.080 |
Why?
|
Molecular Weight | 4 | 2000 | 2255 | 0.080 |
Why?
|
Organ Specificity | 5 | 2011 | 2003 | 0.080 |
Why?
|
HLA-DQ Antigens | 1 | 2009 | 210 | 0.080 |
Why?
|
Cross-Linking Reagents | 3 | 2014 | 694 | 0.080 |
Why?
|
Peritonitis | 2 | 2011 | 365 | 0.080 |
Why?
|
Epitopes | 5 | 2009 | 2569 | 0.080 |
Why?
|
Azoxymethane | 1 | 2008 | 36 | 0.080 |
Why?
|
Simian immunodeficiency virus | 2 | 2014 | 846 | 0.080 |
Why?
|
Pedigree | 2 | 2014 | 4646 | 0.080 |
Why?
|
Helicobacter pylori | 1 | 2011 | 381 | 0.080 |
Why?
|
Mucins | 1 | 2011 | 564 | 0.080 |
Why?
|
Secretory Vesicles | 1 | 2009 | 124 | 0.080 |
Why?
|
Phospholipids | 1 | 2012 | 781 | 0.080 |
Why?
|
Immunoblotting | 2 | 2006 | 1683 | 0.080 |
Why?
|
Helicobacter Infections | 1 | 2011 | 385 | 0.080 |
Why?
|
Hematopoietic System | 1 | 2008 | 108 | 0.080 |
Why?
|
Cell Degranulation | 1 | 2009 | 287 | 0.080 |
Why?
|
Lactobacillus | 1 | 2009 | 189 | 0.080 |
Why?
|
Bone Marrow Transplantation | 2 | 2018 | 2763 | 0.080 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 1995 | 1320 | 0.080 |
Why?
|
Chemokines | 4 | 2010 | 954 | 0.080 |
Why?
|
Peroxisomes | 1 | 2008 | 58 | 0.080 |
Why?
|
Jejunum | 3 | 2002 | 480 | 0.080 |
Why?
|
Heterozygote | 1 | 2014 | 2790 | 0.080 |
Why?
|
Esophagus | 1 | 2014 | 1017 | 0.080 |
Why?
|
Transglutaminases | 1 | 2009 | 194 | 0.080 |
Why?
|
Fetus | 3 | 2003 | 1879 | 0.080 |
Why?
|
Endosomes | 3 | 2019 | 520 | 0.080 |
Why?
|
Mutagenesis, Site-Directed | 3 | 2014 | 1723 | 0.080 |
Why?
|
T-Box Domain Proteins | 3 | 2008 | 471 | 0.080 |
Why?
|
Recombinant Proteins | 5 | 2005 | 6608 | 0.080 |
Why?
|
DNA Mutational Analysis | 2 | 2014 | 4187 | 0.080 |
Why?
|
HMGB1 Protein | 1 | 2008 | 131 | 0.080 |
Why?
|
Melanoma, Experimental | 2 | 2008 | 559 | 0.080 |
Why?
|
AIDS-Related Complex | 1 | 1987 | 111 | 0.080 |
Why?
|
Bacterial Infections | 3 | 2004 | 1389 | 0.070 |
Why?
|
Communicable Diseases | 2 | 2007 | 878 | 0.070 |
Why?
|
Host-Pathogen Interactions | 1 | 2016 | 1477 | 0.070 |
Why?
|
Endotoxemia | 1 | 2008 | 206 | 0.070 |
Why?
|
Hemochromatosis | 1 | 1988 | 184 | 0.070 |
Why?
|
Calmodulin | 1 | 2007 | 209 | 0.070 |
Why?
|
Disease Management | 1 | 2018 | 2450 | 0.070 |
Why?
|
Salmonella typhimurium | 1 | 2009 | 351 | 0.070 |
Why?
|
Genome, Human | 1 | 2000 | 4420 | 0.070 |
Why?
|
Toll-Like Receptor 2 | 3 | 2022 | 354 | 0.070 |
Why?
|
Antigens, CD19 | 1 | 2009 | 379 | 0.070 |
Why?
|
Glutens | 1 | 2009 | 230 | 0.070 |
Why?
|
Sequence Analysis, DNA | 2 | 2014 | 4801 | 0.070 |
Why?
|
Neurons | 1 | 2006 | 9325 | 0.070 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2008 | 438 | 0.070 |
Why?
|
Sequence Alignment | 4 | 2005 | 2257 | 0.070 |
Why?
|
Feces | 2 | 2010 | 1394 | 0.070 |
Why?
|
Cytomegalovirus Infections | 3 | 2016 | 817 | 0.070 |
Why?
|
Lymphocytes | 4 | 2005 | 2614 | 0.070 |
Why?
|
Receptors, Chemokine | 2 | 2010 | 669 | 0.070 |
Why?
|
Eosinophil Major Basic Protein | 1 | 2005 | 14 | 0.070 |
Why?
|
Heme Oxygenase-1 | 1 | 2008 | 381 | 0.070 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 2008 | 482 | 0.070 |
Why?
|
Proteins | 1 | 2001 | 6096 | 0.070 |
Why?
|
Nitric Oxide Synthase Type II | 2 | 2005 | 534 | 0.070 |
Why?
|
Child Development | 1 | 2017 | 2222 | 0.070 |
Why?
|
Premature Birth | 1 | 2018 | 1713 | 0.070 |
Why?
|
Fatty Liver | 1 | 2012 | 728 | 0.070 |
Why?
|
Bronchial Hyperreactivity | 1 | 2007 | 319 | 0.070 |
Why?
|
Lysine | 1 | 1990 | 1008 | 0.070 |
Why?
|
Double-Blind Method | 1 | 2019 | 12017 | 0.070 |
Why?
|
Cryptosporidium parvum | 1 | 2005 | 43 | 0.070 |
Why?
|
Adult | 23 | 2021 | 213712 | 0.070 |
Why?
|
Neoplasm Metastasis | 2 | 2017 | 4839 | 0.070 |
Why?
|
Leucine | 2 | 2004 | 560 | 0.070 |
Why?
|
Microscopy, Confocal | 2 | 2004 | 1969 | 0.070 |
Why?
|
Hybridomas | 2 | 2005 | 452 | 0.070 |
Why?
|
Carbohydrate Conformation | 1 | 2005 | 208 | 0.070 |
Why?
|
Cryptosporidiosis | 1 | 2005 | 59 | 0.070 |
Why?
|
Growth Inhibitors | 1 | 2006 | 385 | 0.070 |
Why?
|
Drug Approval | 1 | 2012 | 740 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2009 | 774 | 0.060 |
Why?
|
CHO Cells | 4 | 2002 | 1407 | 0.060 |
Why?
|
Porphyromonas gingivalis | 1 | 2006 | 169 | 0.060 |
Why?
|
Mutation, Missense | 1 | 2014 | 2556 | 0.060 |
Why?
|
Phenotype | 6 | 2018 | 16331 | 0.060 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2017 | 2407 | 0.060 |
Why?
|
Chlamydia trachomatis | 1 | 2007 | 245 | 0.060 |
Why?
|
Endothelial Cells | 1 | 2018 | 3455 | 0.060 |
Why?
|
Mice, Inbred DBA | 1 | 2006 | 642 | 0.060 |
Why?
|
Sepsis | 2 | 2011 | 2589 | 0.060 |
Why?
|
Anticoagulants | 1 | 2020 | 4595 | 0.060 |
Why?
|
Antigens, Ly | 2 | 2004 | 291 | 0.060 |
Why?
|
Coccidiosis | 1 | 1984 | 13 | 0.060 |
Why?
|
Nitric Oxide Synthase | 2 | 2005 | 916 | 0.060 |
Why?
|
Granuloma | 1 | 2007 | 315 | 0.060 |
Why?
|
Antibodies, Neutralizing | 1 | 2014 | 1970 | 0.060 |
Why?
|
Organ Culture Techniques | 2 | 2017 | 808 | 0.060 |
Why?
|
GTP-Binding Proteins | 1 | 2009 | 970 | 0.060 |
Why?
|
Calreticulin | 1 | 2005 | 97 | 0.060 |
Why?
|
Interleukin-8 | 2 | 2005 | 689 | 0.060 |
Why?
|
Absorption | 1 | 2004 | 248 | 0.060 |
Why?
|
Immunity, Maternally-Acquired | 2 | 2002 | 118 | 0.060 |
Why?
|
Bronchoalveolar Lavage Fluid | 2 | 2007 | 766 | 0.060 |
Why?
|
Genes, APC | 2 | 2016 | 159 | 0.060 |
Why?
|
Eosinophils | 2 | 2007 | 953 | 0.060 |
Why?
|
Cricetinae | 4 | 2002 | 2471 | 0.060 |
Why?
|
Adenocarcinoma | 2 | 2021 | 6347 | 0.060 |
Why?
|
Medical Oncology | 1 | 2016 | 2235 | 0.060 |
Why?
|
Synovial Fluid | 1 | 2006 | 394 | 0.060 |
Why?
|
Obesity | 3 | 2024 | 12705 | 0.060 |
Why?
|
Hydroxymethylglutaryl-CoA Synthase | 1 | 2023 | 16 | 0.060 |
Why?
|
United States Food and Drug Administration | 1 | 2012 | 1581 | 0.060 |
Why?
|
Biotinylation | 1 | 2004 | 177 | 0.060 |
Why?
|
Dehydroepiandrosterone | 1 | 2004 | 252 | 0.060 |
Why?
|
Leishmaniasis, Cutaneous | 1 | 2005 | 124 | 0.060 |
Why?
|
Glycosylation | 2 | 1999 | 1123 | 0.060 |
Why?
|
Thyroid Neoplasms | 1 | 2017 | 2274 | 0.060 |
Why?
|
Protein Disulfide-Isomerases | 1 | 2005 | 198 | 0.060 |
Why?
|
Gingiva | 1 | 2006 | 388 | 0.060 |
Why?
|
Cholecystitis | 1 | 1984 | 182 | 0.060 |
Why?
|
Immunization | 2 | 2018 | 1255 | 0.060 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2006 | 595 | 0.060 |
Why?
|
Disulfides | 1 | 2005 | 457 | 0.060 |
Why?
|
Gene Silencing | 2 | 2014 | 1538 | 0.060 |
Why?
|
Antibodies, Blocking | 2 | 2018 | 254 | 0.060 |
Why?
|
Leukocytes, Mononuclear | 2 | 1987 | 1835 | 0.060 |
Why?
|
Genitalia | 1 | 2023 | 111 | 0.060 |
Why?
|
Detergents | 2 | 2000 | 230 | 0.060 |
Why?
|
Epidermal Growth Factor | 1 | 2006 | 709 | 0.060 |
Why?
|
Interleukin-1beta | 1 | 2008 | 972 | 0.060 |
Why?
|
Butyrates | 1 | 2023 | 163 | 0.060 |
Why?
|
Permeability | 1 | 2005 | 738 | 0.060 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2009 | 1121 | 0.050 |
Why?
|
Young Adult | 5 | 2021 | 56350 | 0.050 |
Why?
|
Interleukin-6 | 3 | 2013 | 3199 | 0.050 |
Why?
|
Staphylococcus aureus | 2 | 2009 | 1449 | 0.050 |
Why?
|
Interleukin-1 | 2 | 2004 | 1262 | 0.050 |
Why?
|
Chromosome Mapping | 1 | 2011 | 4742 | 0.050 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2004 | 2906 | 0.050 |
Why?
|
Time Factors | 6 | 2008 | 40054 | 0.050 |
Why?
|
Transplantation, Isogeneic | 1 | 2002 | 257 | 0.050 |
Why?
|
SH2 Domain-Containing Protein Tyrosine Phosphatases | 1 | 2002 | 45 | 0.050 |
Why?
|
Transcription Factor AP-1 | 1 | 2004 | 317 | 0.050 |
Why?
|
Multigene Family | 4 | 2001 | 1102 | 0.050 |
Why?
|
Age Factors | 2 | 2017 | 18355 | 0.050 |
Why?
|
Cytochrome P-450 CYP2E1 | 1 | 2022 | 36 | 0.050 |
Why?
|
Drug Discovery | 1 | 2010 | 1057 | 0.050 |
Why?
|
Cell Lineage | 2 | 2022 | 2504 | 0.050 |
Why?
|
Gastroenteritis | 1 | 1984 | 245 | 0.050 |
Why?
|
Nanoparticles | 1 | 2013 | 1902 | 0.050 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2004 | 452 | 0.050 |
Why?
|
Enterotoxins | 2 | 2000 | 368 | 0.050 |
Why?
|
rac1 GTP-Binding Protein | 1 | 2003 | 236 | 0.050 |
Why?
|
Receptors, Interleukin-2 | 2 | 2004 | 573 | 0.050 |
Why?
|
Drug Synergism | 2 | 2005 | 1791 | 0.050 |
Why?
|
Mucin-2 | 1 | 2021 | 49 | 0.050 |
Why?
|
Urea | 1 | 2004 | 449 | 0.050 |
Why?
|
Azathioprine | 1 | 2003 | 355 | 0.050 |
Why?
|
Cell Culture Techniques | 4 | 2020 | 1670 | 0.050 |
Why?
|
Protein Kinases | 1 | 2008 | 1638 | 0.050 |
Why?
|
RNA, Antisense | 1 | 2002 | 138 | 0.050 |
Why?
|
Injections, Intraperitoneal | 1 | 2002 | 424 | 0.050 |
Why?
|
Melanoma | 3 | 2006 | 5462 | 0.050 |
Why?
|
Glutamine | 1 | 2004 | 574 | 0.050 |
Why?
|
Gene Transfer Techniques | 2 | 2008 | 1224 | 0.050 |
Why?
|
Dermatitis, Atopic | 1 | 2008 | 653 | 0.050 |
Why?
|
SOX9 Transcription Factor | 1 | 2022 | 146 | 0.050 |
Why?
|
Genes, T-Cell Receptor alpha | 1 | 2000 | 19 | 0.050 |
Why?
|
Receptors, KIR | 1 | 2001 | 113 | 0.050 |
Why?
|
Macromolecular Substances | 4 | 1991 | 1456 | 0.050 |
Why?
|
src Homology Domains | 1 | 2002 | 364 | 0.050 |
Why?
|
Gene Expression | 5 | 2005 | 7790 | 0.050 |
Why?
|
HIV Seropositivity | 1 | 1987 | 970 | 0.050 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2002 | 234 | 0.050 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2006 | 1038 | 0.050 |
Why?
|
Kidney | 4 | 2017 | 7167 | 0.050 |
Why?
|
Fatty Acids, Volatile | 1 | 2021 | 101 | 0.050 |
Why?
|
Child | 8 | 2023 | 77478 | 0.050 |
Why?
|
Viral Load | 1 | 2009 | 3292 | 0.050 |
Why?
|
Golgi Apparatus | 1 | 2002 | 410 | 0.050 |
Why?
|
Muramidase | 1 | 2020 | 174 | 0.050 |
Why?
|
Chemokines, CX3C | 1 | 2000 | 12 | 0.050 |
Why?
|
B-Lymphocyte Subsets | 1 | 2002 | 246 | 0.050 |
Why?
|
Complementarity Determining Regions | 1 | 2001 | 149 | 0.050 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2004 | 880 | 0.050 |
Why?
|
Centrifugation | 1 | 2000 | 122 | 0.050 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2007 | 1333 | 0.050 |
Why?
|
Neoplasm Transplantation | 2 | 2018 | 2085 | 0.050 |
Why?
|
Half-Life | 2 | 2014 | 658 | 0.050 |
Why?
|
Granulocytes | 2 | 2016 | 546 | 0.050 |
Why?
|
Interleukin-18 | 1 | 2002 | 248 | 0.050 |
Why?
|
DNA Probes | 1 | 2001 | 560 | 0.050 |
Why?
|
Capital Financing | 1 | 2000 | 58 | 0.050 |
Why?
|
Endothelium, Lymphatic | 1 | 2000 | 58 | 0.050 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2002 | 315 | 0.040 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2001 | 380 | 0.040 |
Why?
|
G(M1) Ganglioside | 1 | 2000 | 99 | 0.040 |
Why?
|
Immunization, Passive | 2 | 2014 | 625 | 0.040 |
Why?
|
Genes, Reporter | 1 | 2004 | 1547 | 0.040 |
Why?
|
Mice, SCID | 2 | 2002 | 2715 | 0.040 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2003 | 902 | 0.040 |
Why?
|
Adolescent | 7 | 2021 | 85649 | 0.040 |
Why?
|
Hexosaminidases | 1 | 1999 | 54 | 0.040 |
Why?
|
Immunoglobulins | 2 | 2003 | 880 | 0.040 |
Why?
|
Enzyme Activation | 3 | 2013 | 3701 | 0.040 |
Why?
|
Education, Medical | 1 | 2011 | 1717 | 0.040 |
Why?
|
Carcinoma, Lewis Lung | 1 | 2019 | 114 | 0.040 |
Why?
|
Lymph Nodes | 2 | 2009 | 3465 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2016 | 4751 | 0.040 |
Why?
|
Phagocytes | 1 | 2021 | 297 | 0.040 |
Why?
|
Escherichia coli | 2 | 2009 | 4214 | 0.040 |
Why?
|
Immune Sera | 2 | 2006 | 641 | 0.040 |
Why?
|
Organophosphorus Compounds | 1 | 2020 | 215 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2004 | 1284 | 0.040 |
Why?
|
Living Donors | 1 | 2023 | 618 | 0.040 |
Why?
|
Nematospiroides dubius | 1 | 2018 | 35 | 0.040 |
Why?
|
Glucose | 2 | 2024 | 4391 | 0.040 |
Why?
|
HIV Antibodies | 3 | 2014 | 1320 | 0.040 |
Why?
|
Fetal Blood | 2 | 2015 | 1317 | 0.040 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2022 | 546 | 0.040 |
Why?
|
Plasmids | 1 | 2004 | 2305 | 0.040 |
Why?
|
Integrin beta Chains | 1 | 2018 | 121 | 0.040 |
Why?
|
Liver Cirrhosis | 1 | 1988 | 1864 | 0.040 |
Why?
|
Pyrans | 1 | 2018 | 53 | 0.040 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2019 | 310 | 0.040 |
Why?
|
Fucosyltransferases | 1 | 2018 | 119 | 0.040 |
Why?
|
Graft Rejection | 2 | 2004 | 4393 | 0.040 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2001 | 659 | 0.040 |
Why?
|
Histocompatibility Antigens Class II | 2 | 2000 | 1470 | 0.040 |
Why?
|
GATA3 Transcription Factor | 1 | 2018 | 157 | 0.040 |
Why?
|
Industry | 1 | 2000 | 365 | 0.040 |
Why?
|
Hypoxia, Brain | 1 | 1998 | 133 | 0.040 |
Why?
|
DNA Methylation | 1 | 2012 | 4282 | 0.040 |
Why?
|
Immunoglobulin Variable Region | 1 | 1999 | 421 | 0.040 |
Why?
|
Rabbits | 1 | 2004 | 4886 | 0.040 |
Why?
|
Genetic Variation | 5 | 2018 | 6540 | 0.040 |
Why?
|
Respiration | 1 | 2004 | 1645 | 0.040 |
Why?
|
Liver Neoplasms | 2 | 2015 | 4249 | 0.040 |
Why?
|
Bone Marrow Cells | 1 | 2005 | 2513 | 0.040 |
Why?
|
Mast-Cell Sarcoma | 1 | 1997 | 47 | 0.040 |
Why?
|
Cell Separation | 2 | 2003 | 1749 | 0.040 |
Why?
|
Temperature | 1 | 2004 | 2207 | 0.040 |
Why?
|
Middle Aged | 11 | 2021 | 213127 | 0.040 |
Why?
|
Knee Joint | 1 | 2006 | 1679 | 0.040 |
Why?
|
Chemotaxis | 2 | 2014 | 607 | 0.040 |
Why?
|
Shock, Septic | 1 | 2004 | 773 | 0.040 |
Why?
|
Cell Death | 1 | 2022 | 1695 | 0.040 |
Why?
|
Cohort Studies | 1 | 2019 | 40450 | 0.040 |
Why?
|
Leadership | 1 | 2006 | 1357 | 0.040 |
Why?
|
Financing, Government | 1 | 2000 | 468 | 0.040 |
Why?
|
Interleukin-12 Subunit p40 | 2 | 2007 | 55 | 0.040 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2000 | 780 | 0.040 |
Why?
|
Cell Adhesion | 2 | 2001 | 3139 | 0.040 |
Why?
|
DNA Nucleotidylexotransferase | 1 | 1996 | 64 | 0.030 |
Why?
|
Carcinoma, Hepatocellular | 1 | 1988 | 2211 | 0.030 |
Why?
|
Sequence Analysis | 1 | 1997 | 256 | 0.030 |
Why?
|
HIV Antigens | 2 | 1987 | 347 | 0.030 |
Why?
|
Culture Media, Conditioned | 1 | 1997 | 533 | 0.030 |
Why?
|
Chronic Disease | 3 | 2021 | 9144 | 0.030 |
Why?
|
United States | 4 | 2012 | 69693 | 0.030 |
Why?
|
Macaca mulatta | 2 | 2014 | 2378 | 0.030 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2016 | 300 | 0.030 |
Why?
|
Biopsy | 2 | 2020 | 6756 | 0.030 |
Why?
|
Interferon Regulatory Factor-3 | 1 | 2016 | 123 | 0.030 |
Why?
|
Homeodomain Proteins | 2 | 2002 | 2417 | 0.030 |
Why?
|
MicroRNAs | 1 | 2011 | 3731 | 0.030 |
Why?
|
Retroviridae Infections | 2 | 1986 | 151 | 0.030 |
Why?
|
K562 Cells | 1 | 2017 | 632 | 0.030 |
Why?
|
Cell Migration Assays | 1 | 2014 | 23 | 0.030 |
Why?
|
HCT116 Cells | 1 | 2016 | 408 | 0.030 |
Why?
|
Models, Structural | 1 | 1995 | 361 | 0.030 |
Why?
|
Models, Animal | 1 | 2021 | 2170 | 0.030 |
Why?
|
Administration, Rectal | 1 | 2014 | 73 | 0.030 |
Why?
|
Papain | 1 | 2014 | 64 | 0.030 |
Why?
|
Twins, Monozygotic | 1 | 1996 | 458 | 0.030 |
Why?
|
Brain Chemistry | 1 | 1998 | 981 | 0.030 |
Why?
|
Molecular Probes | 1 | 1996 | 316 | 0.030 |
Why?
|
HIV Envelope Protein gp160 | 1 | 2014 | 99 | 0.030 |
Why?
|
Cytoskeleton | 1 | 2019 | 1185 | 0.030 |
Why?
|
Diseases in Twins | 1 | 1996 | 450 | 0.030 |
Why?
|
Antioxidants | 1 | 2002 | 1659 | 0.030 |
Why?
|
Calcium | 1 | 2007 | 5753 | 0.030 |
Why?
|
Databases, Genetic | 1 | 2021 | 1780 | 0.030 |
Why?
|
Acute Disease | 2 | 2002 | 7141 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2016 | 553 | 0.030 |
Why?
|
Genetic Vectors | 3 | 2002 | 3420 | 0.030 |
Why?
|
Societies, Medical | 1 | 2006 | 3740 | 0.030 |
Why?
|
Sirolimus | 1 | 2021 | 1562 | 0.030 |
Why?
|
Transcription Factor CHOP | 1 | 2014 | 73 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2018 | 62966 | 0.030 |
Why?
|
Antibody Affinity | 1 | 2014 | 253 | 0.030 |
Why?
|
Interleukin-11 | 1 | 2013 | 62 | 0.030 |
Why?
|
Janus Kinase 1 | 1 | 2013 | 104 | 0.030 |
Why?
|
Immunoprecipitation | 2 | 2007 | 905 | 0.030 |
Why?
|
Histocompatibility Antigens | 1 | 1994 | 471 | 0.030 |
Why?
|
MAP Kinase Kinase 4 | 1 | 2013 | 148 | 0.030 |
Why?
|
Escherichia coli Proteins | 1 | 2000 | 1052 | 0.030 |
Why?
|
In Situ Hybridization | 1 | 1997 | 1950 | 0.030 |
Why?
|
Hemagglutinins | 1 | 2013 | 117 | 0.030 |
Why?
|
Aspirin | 1 | 2005 | 3278 | 0.030 |
Why?
|
Rats, Inbred Lew | 3 | 2002 | 1161 | 0.030 |
Why?
|
Aging | 1 | 2012 | 8626 | 0.030 |
Why?
|
Hypoglycemic Agents | 2 | 2002 | 2866 | 0.030 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 1998 | 1121 | 0.030 |
Why?
|
Gene Regulatory Networks | 1 | 2021 | 1707 | 0.030 |
Why?
|
Intracellular Space | 1 | 2014 | 212 | 0.030 |
Why?
|
Immunological Synapses | 1 | 2012 | 54 | 0.030 |
Why?
|
Drug Delivery Systems | 1 | 2004 | 2217 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2012 | 12220 | 0.030 |
Why?
|
Microscopy | 1 | 2017 | 903 | 0.030 |
Why?
|
Tissue Engineering | 1 | 2002 | 1877 | 0.030 |
Why?
|
Isoantigens | 1 | 1994 | 567 | 0.030 |
Why?
|
Immunophenotyping | 1 | 1997 | 1866 | 0.030 |
Why?
|
Glycolipids | 2 | 2005 | 205 | 0.030 |
Why?
|
Conserved Sequence | 1 | 1995 | 1202 | 0.030 |
Why?
|
Serine Endopeptidases | 1 | 1997 | 1073 | 0.030 |
Why?
|
Extracellular Space | 1 | 2014 | 594 | 0.030 |
Why?
|
HIV-1 | 1 | 2009 | 6934 | 0.030 |
Why?
|
Protein Structure, Secondary | 1 | 1995 | 1245 | 0.030 |
Why?
|
Glycosylphosphatidylinositols | 2 | 2004 | 94 | 0.030 |
Why?
|
Fas Ligand Protein | 2 | 2006 | 217 | 0.030 |
Why?
|
Membrane Microdomains | 1 | 2012 | 202 | 0.030 |
Why?
|
Receptors, Transferrin | 1 | 2013 | 296 | 0.030 |
Why?
|
Forecasting | 1 | 2001 | 2948 | 0.030 |
Why?
|
Lung Neoplasms | 3 | 2017 | 13019 | 0.030 |
Why?
|
Piperidines | 1 | 2020 | 1602 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 1 | 2001 | 1788 | 0.020 |
Why?
|
Reference Values | 1 | 1999 | 4982 | 0.020 |
Why?
|
Virus Diseases | 2 | 1990 | 710 | 0.020 |
Why?
|
Phospholipid Transfer Proteins | 1 | 2012 | 91 | 0.020 |
Why?
|
Alleles | 1 | 2022 | 6931 | 0.020 |
Why?
|
Oligonucleotide Probes | 1 | 1991 | 427 | 0.020 |
Why?
|
Radiation Injuries, Experimental | 1 | 2011 | 91 | 0.020 |
Why?
|
Bacterial Outer Membrane Proteins | 1 | 2014 | 404 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2021 | 2948 | 0.020 |
Why?
|
Case-Control Studies | 3 | 2007 | 21719 | 0.020 |
Why?
|
Porins | 1 | 2010 | 81 | 0.020 |
Why?
|
Heart Transplantation | 1 | 2004 | 3119 | 0.020 |
Why?
|
GPI-Linked Proteins | 2 | 2004 | 434 | 0.020 |
Why?
|
Radiation, Ionizing | 1 | 2011 | 258 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2016 | 1769 | 0.020 |
Why?
|
Biodiversity | 1 | 2013 | 341 | 0.020 |
Why?
|
Influenza, Human | 2 | 2016 | 1472 | 0.020 |
Why?
|
Lipogenesis | 1 | 2012 | 212 | 0.020 |
Why?
|
Random Allocation | 2 | 2012 | 2425 | 0.020 |
Why?
|
Peroxidase | 2 | 2005 | 610 | 0.020 |
Why?
|
Virus Replication | 2 | 2016 | 2531 | 0.020 |
Why?
|
Cancer Vaccines | 2 | 2010 | 1021 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2016 | 2638 | 0.020 |
Why?
|
Homosexuality | 2 | 1987 | 264 | 0.020 |
Why?
|
Diet, Atherogenic | 1 | 2009 | 95 | 0.020 |
Why?
|
Cell Movement | 2 | 2014 | 5212 | 0.020 |
Why?
|
Cell Membrane Permeability | 1 | 2011 | 590 | 0.020 |
Why?
|
DNA, Viral | 1 | 2016 | 2224 | 0.020 |
Why?
|
Rectum | 1 | 2014 | 903 | 0.020 |
Why?
|
Tissue Distribution | 1 | 1993 | 2335 | 0.020 |
Why?
|
Myosin Type V | 1 | 2009 | 34 | 0.020 |
Why?
|
Administration, Oral | 2 | 2013 | 3913 | 0.020 |
Why?
|
Biliverdine | 1 | 2008 | 29 | 0.020 |
Why?
|
Bloodletting | 1 | 1988 | 23 | 0.020 |
Why?
|
Protein Biosynthesis | 1 | 2016 | 2126 | 0.020 |
Why?
|
Child, Preschool | 4 | 2017 | 40955 | 0.020 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2010 | 286 | 0.020 |
Why?
|
Infant, Premature | 1 | 2018 | 2041 | 0.020 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2011 | 697 | 0.020 |
Why?
|
Caveolin 1 | 2 | 2000 | 264 | 0.020 |
Why?
|
Cell Compartmentation | 1 | 2009 | 402 | 0.020 |
Why?
|
GATA6 Transcription Factor | 1 | 2008 | 50 | 0.020 |
Why?
|
Matrix Metalloproteinases | 1 | 2010 | 391 | 0.020 |
Why?
|
Respiratory Hypersensitivity | 1 | 2010 | 274 | 0.020 |
Why?
|
Immunologic Surveillance | 1 | 2008 | 93 | 0.020 |
Why?
|
Proviruses | 1 | 2009 | 316 | 0.020 |
Why?
|
HIV Infections | 1 | 2014 | 16678 | 0.020 |
Why?
|
Receptors, Interleukin-12 | 1 | 2007 | 26 | 0.020 |
Why?
|
Neoplastic Stem Cells | 1 | 2016 | 1376 | 0.020 |
Why?
|
Phytohemagglutinins | 2 | 2003 | 170 | 0.020 |
Why?
|
Transplantation, Homologous | 2 | 2011 | 4771 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2010 | 766 | 0.020 |
Why?
|
Virulence | 1 | 2011 | 1328 | 0.020 |
Why?
|
Tumor Burden | 1 | 2013 | 1905 | 0.020 |
Why?
|
STAT4 Transcription Factor | 1 | 2007 | 96 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2013 | 2088 | 0.020 |
Why?
|
Lactation | 1 | 2010 | 412 | 0.020 |
Why?
|
GATA4 Transcription Factor | 1 | 2008 | 130 | 0.020 |
Why?
|
Myosin Heavy Chains | 1 | 2009 | 414 | 0.020 |
Why?
|
HLA-C Antigens | 1 | 2007 | 147 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2016 | 3471 | 0.020 |
Why?
|
Rats, Inbred WF | 2 | 1998 | 140 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2008 | 898 | 0.020 |
Why?
|
Muscle, Smooth, Vascular | 1 | 1993 | 1504 | 0.020 |
Why?
|
Rats, Inbred BN | 2 | 1999 | 235 | 0.020 |
Why?
|
Thymidine | 1 | 1987 | 309 | 0.020 |
Why?
|
Vitamin D | 1 | 2020 | 3211 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2016 | 2107 | 0.020 |
Why?
|
Aged | 7 | 2021 | 162944 | 0.020 |
Why?
|
Integrins | 1 | 2011 | 845 | 0.020 |
Why?
|
Calcium-Binding Proteins | 1 | 2011 | 1081 | 0.020 |
Why?
|
Interleukin-5 | 1 | 2007 | 273 | 0.020 |
Why?
|
Intracellular Fluid | 1 | 2006 | 203 | 0.020 |
Why?
|
Clathrin-Coated Vesicles | 1 | 2006 | 74 | 0.020 |
Why?
|
Carbohydrate Metabolism | 1 | 2007 | 264 | 0.020 |
Why?
|
Bacterial Physiological Phenomena | 1 | 2007 | 122 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2008 | 480 | 0.020 |
Why?
|
Fibroblasts | 1 | 1997 | 4143 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2008 | 1420 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2008 | 489 | 0.020 |
Why?
|
Drug Therapy | 1 | 2009 | 497 | 0.020 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 1986 | 248 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6534 | 0.020 |
Why?
|
Carbon Monoxide | 1 | 2008 | 531 | 0.020 |
Why?
|
Gene Knockout Techniques | 1 | 2008 | 808 | 0.020 |
Why?
|
Survivors | 1 | 2016 | 2286 | 0.020 |
Why?
|
Leishmania major | 1 | 2005 | 57 | 0.020 |
Why?
|
Cell Transplantation | 1 | 2007 | 477 | 0.020 |
Why?
|
Receptors, NK Cell Lectin-Like | 1 | 2004 | 30 | 0.020 |
Why?
|
Rubella | 1 | 1985 | 48 | 0.020 |
Why?
|
Concanavalin A | 1 | 2004 | 191 | 0.020 |
Why?
|
RNA Caps | 1 | 2005 | 74 | 0.020 |
Why?
|
Parasitic Diseases | 1 | 1985 | 75 | 0.020 |
Why?
|
Coccidia | 1 | 1984 | 3 | 0.020 |
Why?
|
Phosphatidylethanolamines | 1 | 2005 | 134 | 0.020 |
Why?
|
Leprosy | 1 | 1985 | 127 | 0.020 |
Why?
|
Quaternary Ammonium Compounds | 1 | 2005 | 205 | 0.020 |
Why?
|
Bacteremia | 1 | 2011 | 962 | 0.020 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2007 | 707 | 0.020 |
Why?
|
Mumps | 1 | 1985 | 64 | 0.020 |
Why?
|
Metalloproteases | 1 | 2004 | 62 | 0.020 |
Why?
|
Receptors, CCR2 | 1 | 2005 | 212 | 0.020 |
Why?
|
Bystander Effect | 1 | 2004 | 81 | 0.020 |
Why?
|
Chickenpox | 1 | 1985 | 131 | 0.020 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2005 | 428 | 0.020 |
Why?
|
Gangrene | 1 | 1984 | 82 | 0.020 |
Why?
|
Antiviral Agents | 2 | 1987 | 2978 | 0.020 |
Why?
|
DNA Fragmentation | 1 | 2004 | 242 | 0.020 |
Why?
|
Brain Ischemia | 1 | 1998 | 3258 | 0.020 |
Why?
|
Receptors, CXCR3 | 1 | 2005 | 237 | 0.020 |
Why?
|
Vero Cells | 1 | 2005 | 485 | 0.010 |
Why?
|
Prevalence | 1 | 2001 | 15194 | 0.010 |
Why?
|
Fatty Acids | 1 | 2012 | 1806 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 1995 | 8300 | 0.010 |
Why?
|
Aged, 80 and over | 3 | 2018 | 57683 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2009 | 1372 | 0.010 |
Why?
|
Toll-Like Receptor 9 | 1 | 2005 | 212 | 0.010 |
Why?
|
Chemokine CXCL2 | 1 | 2003 | 111 | 0.010 |
Why?
|
Infant | 2 | 2017 | 35070 | 0.010 |
Why?
|
Hypersensitivity, Delayed | 1 | 2004 | 485 | 0.010 |
Why?
|
Mice, Inbred CBA | 1 | 2004 | 447 | 0.010 |
Why?
|
Antigens, Protozoan | 1 | 2005 | 322 | 0.010 |
Why?
|
NIH 3T3 Cells | 1 | 2005 | 677 | 0.010 |
Why?
|
Administration, Topical | 1 | 2005 | 688 | 0.010 |
Why?
|
Environmental Exposure | 1 | 2017 | 4231 | 0.010 |
Why?
|
Leukocyte Count | 1 | 1987 | 1583 | 0.010 |
Why?
|
Dermatitis | 1 | 2005 | 197 | 0.010 |
Why?
|
Measles | 1 | 1985 | 168 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2012 | 6365 | 0.010 |
Why?
|
Complement System Proteins | 1 | 1986 | 795 | 0.010 |
Why?
|
Interferon-alpha | 1 | 2007 | 895 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3920 | 0.010 |
Why?
|
Graft Survival | 2 | 2004 | 3733 | 0.010 |
Why?
|
Gallbladder | 1 | 1984 | 301 | 0.010 |
Why?
|
Herpes Zoster | 1 | 1985 | 264 | 0.010 |
Why?
|
Amides | 1 | 2005 | 458 | 0.010 |
Why?
|
Employment | 1 | 1989 | 1124 | 0.010 |
Why?
|
Respiratory Tract Infections | 1 | 1990 | 959 | 0.010 |
Why?
|
DNA | 1 | 1996 | 7289 | 0.010 |
Why?
|
Peptides | 1 | 1994 | 4392 | 0.010 |
Why?
|
Sheep | 1 | 2005 | 1437 | 0.010 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 329 | 0.010 |
Why?
|
Haiti | 1 | 1984 | 551 | 0.010 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 2002 | 329 | 0.010 |
Why?
|
I-kappa B Kinase | 1 | 2003 | 251 | 0.010 |
Why?
|
Mycoses | 1 | 1985 | 376 | 0.010 |
Why?
|
Herpes Simplex | 1 | 1985 | 466 | 0.010 |
Why?
|
Toll-Like Receptors | 1 | 2005 | 592 | 0.010 |
Why?
|
Chloroquine | 1 | 1982 | 280 | 0.010 |
Why?
|
Lectins, C-Type | 1 | 2004 | 588 | 0.010 |
Why?
|
Genotype | 1 | 2016 | 12946 | 0.010 |
Why?
|
Gene Targeting | 1 | 2004 | 880 | 0.010 |
Why?
|
Antibody Diversity | 1 | 2000 | 74 | 0.010 |
Why?
|
Inflammation Mediators | 1 | 2010 | 1889 | 0.010 |
Why?
|
Risk Factors | 3 | 2017 | 72145 | 0.010 |
Why?
|
Serine | 1 | 2004 | 828 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2010 | 2968 | 0.010 |
Why?
|
Superantigens | 1 | 2000 | 129 | 0.010 |
Why?
|
Forkhead Transcription Factors | 1 | 2007 | 1613 | 0.010 |
Why?
|
Membranes | 1 | 2000 | 173 | 0.010 |
Why?
|
Chemokine CX3CL1 | 1 | 2000 | 58 | 0.010 |
Why?
|
Skin | 1 | 1993 | 4353 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2014 | 12242 | 0.010 |
Why?
|
Lymphoma | 1 | 2009 | 1873 | 0.010 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2001 | 424 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-fyn | 1 | 1999 | 116 | 0.010 |
Why?
|
Culture Techniques | 1 | 2000 | 554 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 2004 | 1792 | 0.010 |
Why?
|
Cricetulus | 1 | 2001 | 817 | 0.010 |
Why?
|
Saccharomyces cerevisiae | 1 | 2010 | 2749 | 0.010 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 1 | 2000 | 318 | 0.010 |
Why?
|
Receptors, HIV | 1 | 2000 | 162 | 0.010 |
Why?
|
Hepatitis B | 1 | 1985 | 695 | 0.010 |
Why?
|
Mink | 1 | 1999 | 44 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2007 | 2699 | 0.010 |
Why?
|
Polyethylene Glycols | 1 | 2005 | 1181 | 0.010 |
Why?
|
False Negative Reactions | 1 | 2000 | 587 | 0.010 |
Why?
|
Body Weight | 1 | 2010 | 4664 | 0.010 |
Why?
|
Cattle | 1 | 2005 | 3923 | 0.010 |
Why?
|
Genetic Engineering | 1 | 2005 | 952 | 0.010 |
Why?
|
Anastomosis, Surgical | 1 | 2002 | 985 | 0.010 |
Why?
|
Logistic Models | 1 | 2014 | 13403 | 0.010 |
Why?
|
Family Health | 1 | 2003 | 1282 | 0.010 |
Why?
|
Intestinal Absorption | 1 | 1999 | 420 | 0.010 |
Why?
|
Disease Progression | 2 | 2007 | 13256 | 0.010 |
Why?
|
Recurrence | 1 | 1990 | 8333 | 0.010 |
Why?
|
Erysipelothrix Infections | 1 | 1977 | 5 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2014 | 13921 | 0.010 |
Why?
|
Crosses, Genetic | 1 | 1999 | 791 | 0.010 |
Why?
|
Mice, Inbred C3H | 1 | 1999 | 964 | 0.010 |
Why?
|
Rats, Inbred Strains | 1 | 1999 | 2191 | 0.010 |
Why?
|
Pore Forming Cytotoxic Proteins | 1 | 1997 | 130 | 0.010 |
Why?
|
Perforin | 1 | 1997 | 168 | 0.010 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2000 | 675 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2012 | 14720 | 0.010 |
Why?
|
Cell Division | 1 | 2004 | 4564 | 0.010 |
Why?
|
Granzymes | 1 | 1997 | 270 | 0.010 |
Why?
|
Prognosis | 1 | 2016 | 29010 | 0.010 |
Why?
|
Basement Membrane | 1 | 1996 | 356 | 0.010 |
Why?
|
Nitric Oxide | 1 | 2004 | 2128 | 0.010 |
Why?
|
Swine | 1 | 2005 | 5934 | 0.010 |
Why?
|
Quality of Life | 1 | 2016 | 12730 | 0.010 |
Why?
|
Survival Rate | 1 | 2008 | 12773 | 0.010 |
Why?
|
Bacterial Toxins | 1 | 2000 | 933 | 0.010 |
Why?
|
Colonoscopy | 1 | 2002 | 1365 | 0.010 |
Why?
|
Regeneration | 1 | 2002 | 1485 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2011 | 19862 | 0.010 |
Why?
|
Endocarditis, Bacterial | 1 | 1977 | 453 | 0.010 |
Why?
|
Lymphocyte Culture Test, Mixed | 1 | 1993 | 517 | 0.010 |
Why?
|
Trans-Activators | 1 | 2003 | 2924 | 0.010 |
Why?
|
Plasmodium falciparum | 1 | 1982 | 1726 | 0.010 |
Why?
|
Malaria | 1 | 1982 | 1232 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2016 | 13655 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2005 | 10943 | 0.010 |
Why?
|
Tuberculosis | 1 | 1985 | 1904 | 0.010 |
Why?
|
Gene Rearrangement | 1 | 1997 | 1179 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2006 | 7721 | 0.010 |
Why?
|
Myocardium | 1 | 2004 | 4775 | 0.010 |
Why?
|
Ethyl Methanesulfonate | 1 | 1990 | 29 | 0.010 |
Why?
|
Receptors, Mitogen | 1 | 1990 | 62 | 0.010 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 1989 | 279 | 0.010 |
Why?
|
Prospective Studies | 1 | 2014 | 53187 | 0.010 |
Why?
|
Pneumonia | 1 | 2001 | 2117 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1989 | 1581 | 0.000 |
Why?
|
Myocardial Infarction | 1 | 1989 | 11690 | 0.000 |
Why?
|
Cell Cycle | 1 | 1996 | 2964 | 0.000 |
Why?
|
Serotyping | 1 | 1987 | 338 | 0.000 |
Why?
|
Proto-Oncogene Proteins | 1 | 1999 | 4553 | 0.000 |
Why?
|
Genes, Viral | 1 | 1987 | 718 | 0.000 |
Why?
|
Vaccinia virus | 1 | 1987 | 349 | 0.000 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2009 | 11695 | 0.000 |
Why?
|
Work Schedule Tolerance | 1 | 1989 | 565 | 0.000 |
Why?
|
Zidovudine | 1 | 1987 | 620 | 0.000 |
Why?
|
Costs and Cost Analysis | 1 | 1989 | 1679 | 0.000 |
Why?
|
Kidney Transplantation | 1 | 1998 | 4246 | 0.000 |
Why?
|
Meningocele | 1 | 1963 | 45 | 0.000 |
Why?
|
Genes | 1 | 1987 | 1892 | 0.000 |
Why?
|
Lymphokines | 1 | 1986 | 949 | 0.000 |
Why?
|
Meningomyelocele | 1 | 1963 | 165 | 0.000 |
Why?
|
Exercise Test | 1 | 1989 | 2075 | 0.000 |
Why?
|
Spinal Dysraphism | 1 | 1963 | 160 | 0.000 |
Why?
|
Staphylococcus | 1 | 1961 | 155 | 0.000 |
Why?
|
Kenya | 1 | 1982 | 685 | 0.000 |
Why?
|
Drug Resistance, Microbial | 1 | 1982 | 860 | 0.000 |
Why?
|
Travel | 1 | 1982 | 788 | 0.000 |
Why?
|
Cost-Benefit Analysis | 1 | 1989 | 5385 | 0.000 |
Why?
|
Brain Diseases | 1 | 1982 | 1554 | 0.000 |
Why?
|
Clinical Trials as Topic | 1 | 1989 | 7901 | 0.000 |
Why?
|
Staphylococcal Infections | 1 | 1961 | 1398 | 0.000 |
Why?
|
Algorithms | 1 | 1989 | 13853 | 0.000 |
Why?
|
Heart Valve Prosthesis | 1 | 1977 | 1486 | 0.000 |
Why?
|
Aortic Valve | 1 | 1977 | 1911 | 0.000 |
Why?
|
Incidence | 1 | 1963 | 20928 | 0.000 |
Why?
|